Records containing: Recurrent Adult Soft Tissue Sarcoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2015-07-30
A Phase 2 Study of Temsirolimus (CCI-779, NSC 683864) and IGF-1 Receptor Antibody Cixutumumab (IMC-A12, NSC 742460) in Patients With Metastatic Sarcomas
CLINICAL_TRIALS study record update · 2015-07-30
A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma
CLINICAL_TRIALS study record update · 2015-07-23
Isolated Limb Perfusion for Advanced Melanoma or Sarcoma Limited to Extremity With or Without Distant Metastases
CLINICAL_TRIALS study record update · 2015-07-02
Phase II Study of the Angiopoietin-1 and -2 Peptibody AMG 386 for the Treatment of Angiosarcoma
CLINICAL_TRIALS study record update · 2015-04-15
A Phase II Study of Epothilone B Analog (BMS-247550) in Advanced Soft Tissue Sarcomas
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2015-03-30
A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, NSC #742460) in Children With Relapsed/Refractory Solid Tumors
CLINICAL_TRIALS study record update · 2015-02-23
A Phase I/II Study of Nelfinavir in Liposarcoma
CLINICAL_TRIALS study record update · 2014-12-11
A Phase I Study To Determine the Feasibility of Using Autologous NY-ESO-1 Specific CD8+ T Cells For the Treatment of Patients With Advanced Myxoid/ Round Cell Liposarcoma and Synovial Sarcoma.
CLINICAL_TRIALS study record update · 2014-11-14
Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults With Refractory Solid Tumors
CLINICAL_TRIALS study record update · 2014-10-08
A Phase 1b/2 Study of Imatinib in Combination With Everolimus in Synovial Sarcoma
CLINICAL_TRIALS study record update · 2014-03-17
A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma
CLINICAL_TRIALS study record update · 2014-01-30
A Phase II Clinical Trial of Angiotensin 1-7 For the Second or Third Line Treatment of Patients With Metastatic or Unresectable Sarcomas
CLINICAL_TRIALS study record update · 2014-01-20
A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas
CLINICAL_TRIALS study record update · 2013-11-21
A Phase II Study of Suberoylanilide Hydroxamic Acid and Bortezomib in Advanced Soft Tissue Sarcomas
CLINICAL_TRIALS study record update · 2013-07-10
A Pilot Phase II Study of Pre-Operative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Pre-Operative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall
CLINICAL_TRIALS study record update · 2013-06-27
Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma
CLINICAL_TRIALS study record update · 2013-06-04
A Phase II Study of Perifosine in Soft Tissue Sarcoma
CLINICAL_TRIALS study record update · 2013-06-04
A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.
CLINICAL_TRIALS study record update · 2013-03-19
Phase I Trial of Doxorubicin and Alvocidib (Flavopiridol; NCI Supplied Agent, NSC 649890) in the Treatment of Metastatic Sarcoma
CLINICAL_TRIALS study record update · 2013-02-28
A Phase II Study of Imatinib (NSC-716051) in Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans
CLINICAL_TRIALS study record update · 2013-02-07
A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin
CLINICAL_TRIALS study record update · 2013-01-16
Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies